Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04946721

2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD

Sponsor: University of Maryland, Baltimore

View on ClinicalTrials.gov

Summary

Evaluate and study the immunologic changes to the ocular surface in cancer patients.

Official title: 2177GCCC: Identifying Novel Treatment Targets and Biomarkers for Ocular Surface Disease in Patients With Ocular Graft vs Host Disease (oGVHD) a Biobank Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

150

Start Date

2022-04-27

Completion Date

2027-12-31

Last Updated

2026-02-03

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

The standard care exam and biological specimens' collection

During each visit, in addition to standard of care exams, certain biological specimens ( ocular surface wash, mucocellular material, corneal filaments or impression cytology of conjunctiva, blood or serum) will be collected.

Locations (1)

Geenebaum Cancer Center, University of Maryland Medical Center

Baltimore, Maryland, United States